These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The neuroimaging and clinical spectrum of neurofibromatosis 2. Mautner VF; Lindenau M; Baser ME; Hazim W; Tatagiba M; Haase W; Samii M; Wais R; Pulst SM Neurosurgery; 1996 May; 38(5):880-5; discussion 885-6. PubMed ID: 8727812 [TBL] [Abstract][Full Text] [Related]
23. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom. Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104 [TBL] [Abstract][Full Text] [Related]
24. Population Characteristics and Progressive Disability in Neurofibromatosis Type 2. Iwatate K; Yokoo T; Iwatate E; Ichikawa M; Sato T; Fujii M; Sakuma J; Saito K World Neurosurg; 2017 Oct; 106():653-660. PubMed ID: 28720529 [TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis 2 in children presenting during the first decade of life. Gaudioso C; Listernick R; Fisher MJ; Campen CJ; Paz A; Gutmann DH Neurology; 2019 Sep; 93(10):e964-e967. PubMed ID: 31363058 [TBL] [Abstract][Full Text] [Related]
26. Ataxia in a Young Female. Jayanthi R; Monica K; Raja K; Gauthaman CS; Arunkumar PP J Assoc Physicians India; 2017 Aug; 65(8):109-110. PubMed ID: 28799319 [TBL] [Abstract][Full Text] [Related]
27. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2. Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213 [TBL] [Abstract][Full Text] [Related]
29. Central nervous system metastases of pulmonary adenocarcinoma mimicking neurofibromatosis type 2. Willekens BM; Rooker S; Dua G; Appel B; Martin JJ; Crols R; De Deyn PP Acta Neurol Belg; 2006 Jun; 106(2):87-9. PubMed ID: 16898259 [TBL] [Abstract][Full Text] [Related]
30. Neurofibromatosis type 2. Slattery WH Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141 [TBL] [Abstract][Full Text] [Related]
31. The ocular presentation of neurofibromatosis 2. Ragge NK; Baser ME; Riccardi VM; Falk RE Eye (Lond); 1997; 11 ( Pt 1)():12-8. PubMed ID: 9246269 [TBL] [Abstract][Full Text] [Related]
32. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria. Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2. Plana-Pla A; Bielsa-Marsol I; Carrato-Moñino C; Actas Dermosifiliogr; 2017 Sep; 108(7):630-636. PubMed ID: 28237041 [TBL] [Abstract][Full Text] [Related]
34. Astrocytic hamartoma of the optic disc and multiple café-au-lait macules in a child with neurofibromatosis type 2. Sachdeva R; Rothner DA; Traboulsi EI; Hayden BC; Rychwalski PJ Ophthalmic Genet; 2010 Dec; 31(4):209-14. PubMed ID: 21067482 [TBL] [Abstract][Full Text] [Related]
35. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Fisher LM; Doherty JK; Lev MH; Slattery WH Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434 [TBL] [Abstract][Full Text] [Related]
36. The diagnosis and management of neurofibromatosis 2 in childhood. MacCollin M; Mautner VF Semin Pediatr Neurol; 1998 Dec; 5(4):243-52. PubMed ID: 9874852 [TBL] [Abstract][Full Text] [Related]
37. Multiple cutaneous plexiform schwannomas as initial presentation of neurofibromatosis 2 in a 9-year-old. Nguyen TV; Matthews MR; Barrera FF; Browning JC Pediatr Dermatol; 2012; 29(4):536-8. PubMed ID: 21906157 [TBL] [Abstract][Full Text] [Related]